Geron to Participate at Upcoming Investor Conferences in March 2025
-
TD Cowen 45th Annual Health Care Conference
Monday, March 3rd at 3:10pm ET (Boston, MA )
-
Leerink Global Healthcare Conference
Monday, March 10th 3:00pm ET (Miami, FL )
-
Barclays 27th Annual Global Healthcare Conference
Tuesday, March 11th 10:30am ET (Miami, FL )
A live webcast of each fireside chat will be available through the Investors & Media section of the Geron’s website under Events. A replay of the webcast will be archived and available on Geron’s website for 30 days.
About Geron
Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO® (imetelstat) is approved in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250221535654/en/
Aron Feingold
Vice President, Investor Relations and Corporate Communications
Kristen Kelleher
Associate Director, Investor Relations and Corporate Communications
investor@geron.com
media@geron.com
Source: Geron Corporation